I have watched that one and many others and yes, that's why
I have watched that one and many others and yes, that's why pharma shuts them down(well really the FDA), ya can't patent mother nature. But you can patent a process to use mother nature.
Two notables that were shut down are Essiac Tea and the Hoxsey cure, both which worked and cured, or at least successfully treated all types of cancer, and were shut down by the fledgling FDA(pharma). These two along with S American propolis contain a common compound found in fresh fruit, quercitin. It is an anti cancer agent that is readily available in refined form, 99% pure. I get mine from India(cheaper)
I mention this because it is one of the only natural compounds that has been tested in vivo and there is I believe at least one trial of some type that has tested it in vitro. It was found to be almost 100% effective in stopping metastasis and also killing the cancer at a specific point in mytosis, doing the same thing as chemo but without side effects and only effects cancer cells, not healthy ones.
Hmmmm, sounds like OWCPs multiple myeloma treatment. Patent a process to use mother natures bounty yo kill cancer and leave healthy cells alone.
3
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Russel Metals Inc. Reports Third Quarter Results for 2025 Russel Metals Inc. (TSX:RUS) has recently shared its financial performance for the three-month period ending September 30, 2025. The results reflect a positive trajectory in revenue and strategic initiatives to enhance its market position. Key Financial Metrics Overview In this quarter, Russel Metals has...
Continue Reading
KBC Group's Capital Position Remains Strong KBC Group has reported a robust standing in its capital levels, significantly exceeding the minimum capital requirements mandated by the European Central Bank (ECB). As part of the Supervisory Review and Evaluation Process (SREP) scheduled for the upcoming year, KBC received formal notification regarding its capital metrics....
Continue Reading
Synlogic Provides Third Quarter 2024 Financial Results Synlogic, Inc. (NASDAQ: SYBX), a prominent biopharmaceutical firm dedicated to developing innovative therapeutics for serious diseases, has recently outlined its financial performance for the third quarter of 2024. The organization is actively working on advancing its mission to enhance healthcare through...
Continue Reading
Incannex Healthcare's Remarkable Financial Progress Incannex Healthcare Inc. (NASDAQ: IXHL) is making impressive strides in the biopharmaceutical world, focusing on breakthrough treatments for chronic diseases. Their recent fiscal year report outlines not only financial outcomes but also a plethora of operational and clinical advancements aimed at addressing significant...
Continue Reading
Alpha Liquid Terminal Introduces ChatAnalyst Financial Agent Recently, a game-changing tool was launched that promises to redefine how individuals manage and interpret financial data. This is powered by the innovative company, Alpha Liquid Terminal. The newly unveiled AI-driven financial analyst agent, known as ChatAnalyst, is designed to simplify and streamline financial...
Continue Reading